<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Journal of Modern Oncology</journal-id><journal-title-group><journal-title xml:lang="en">Journal of Modern Oncology</journal-title><trans-title-group xml:lang="ru"><trans-title>Современная онкология</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1815-1434</issn><issn publication-format="electronic">1815-1442</issn><publisher><publisher-name xml:lang="en">LLC Obyedinennaya Redaktsiya</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">679620</article-id><article-id pub-id-type="doi">10.26442/18151434.2025.3.203331</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Comparative analysis of reconstruction methods in patients with breast cancer using cell-based technologies</article-title><trans-title-group xml:lang="ru"><trans-title>Сравнительный анализ методов реконструкции у больных раком молочной железы с использованием клеточных технологий</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8514-0824</contrib-id><contrib-id contrib-id-type="scopus">58313002400</contrib-id><contrib-id contrib-id-type="researcherid">MVU-9443-2025</contrib-id><contrib-id contrib-id-type="spin">1858-8041</contrib-id><name-alternatives><name xml:lang="en"><surname>Wang</surname><given-names>Shuowen</given-names></name><name xml:lang="ru"><surname>Ван</surname><given-names>Шовэнь</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Graduate Student</p></bio><bio xml:lang="ru"><p>аспирант каф. факультетской хирургии №2 им. Г.И. Лукомского</p></bio><email>wswen1019@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0008-3499-7490</contrib-id><name-alternatives><name xml:lang="en"><surname>Baranova</surname><given-names>Madina P.</given-names></name><name xml:lang="ru"><surname>Баранова</surname><given-names>Мадина Петровна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>канд. мед. наук, зав. отд-нием опухолей молочной железы и кожи Университетской клинической больницы №4 </p></bio><email>wswen1019@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-6141-0511</contrib-id><name-alternatives><name xml:lang="en"><surname>Abbasova</surname><given-names>Daria V.</given-names></name><name xml:lang="ru"><surname>Аббасова</surname><given-names>Дарья Валерьевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Oncologist</p></bio><bio xml:lang="ru"><p>врач отд-ния опухолей молочной железы и кожи</p></bio><email>wswen1019@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8209-042X</contrib-id><name-alternatives><name xml:lang="en"><surname>Kong</surname><given-names>Xiangyi</given-names></name><name xml:lang="ru"><surname>Кун</surname><given-names>Сянъи</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>D. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, вед. врач, проф. отд-ния хирургии молочной железы </p></bio><email>wswen1019@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0009-4841-605X</contrib-id><name-alternatives><name xml:lang="en"><surname>Wang</surname><given-names>Zhongzhao</given-names></name><name xml:lang="ru"><surname>Ван</surname><given-names>Чжунчжао</given-names></name></name-alternatives><address><country country="CN">China</country></address><bio xml:lang="en"><p>Chief doctor</p></bio><bio xml:lang="ru"><p>вед. врач, проф. отд-ния хирургии молочной железы</p></bio><email>wswen1019@gmail.com</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0009-0000-3203-5476</contrib-id><name-alternatives><name xml:lang="en"><surname>Zhou</surname><given-names>Zeting</given-names></name><name xml:lang="ru"><surname>Чжоу</surname><given-names>Цзэтин</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Student</p></bio><bio xml:lang="ru"><p>студент</p></bio><email>wswen1019@gmail.com</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5769-5091</contrib-id><name-alternatives><name xml:lang="en"><surname>Khorobryh</surname><given-names>Tatiana V.</given-names></name><name xml:lang="ru"><surname>Хоробрых</surname><given-names>Татьяна Витальевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>D. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук, проф. РАН, зав. каф. факультетской хирургии №2 им. Г.И. Лукомского</p></bio><email>wswen1019@gmail.com</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Sechenov First Moscow State Medical University (Sechenovskiy University)</institution></aff><aff><institution xml:lang="ru">ФГАОУ ВО «Первый Московский государственный медицинский университет им. И.М. Сеченова» Минздрава России (Сеченовский Университет)</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Chinese Academy of Medical Sciences Cancer Hospital</institution></aff><aff><institution xml:lang="ru">Онкологическая больница Китайской академии медицинских наук</institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Pavlov First Saint Petersburg State Medical University</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Первый Санкт-Петербургский государственный медицинский университет им. акад. И.П. Павлова» Минздрава России</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-08-01" publication-format="electronic"><day>01</day><month>08</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-12-05" publication-format="electronic"><day>05</day><month>12</month><year>2025</year></pub-date><volume>27</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>206</fpage><lpage>211</lpage><history><date date-type="received" iso-8601-date="2025-05-13"><day>13</day><month>05</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-08-01"><day>01</day><month>08</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Consilium Medicum</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, ООО "Консилиум Медикум"</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Consilium Medicum</copyright-holder><copyright-holder xml:lang="ru">ООО "Консилиум Медикум"</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-sa/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://modernonco.orscience.ru/1815-1434/article/view/679620">https://modernonco.orscience.ru/1815-1434/article/view/679620</self-uri><abstract xml:lang="en"><p><bold>Introduction.</bold> Autologous adipose tissue transplantation (AATT) with platelet-rich plasma (PRP) is widely used in reconstructive and aesthetic breast surgery. However, differences in the methods of preparation of PRP and AATT, as well as in the approaches to the management of patients with breast cancer and without malignancies, require a comparative analysis to optimize clinical outcomes.</p> <p><bold>Aim.</bold> To compare the surgical techniques and the results of PRP-assisted AATT in reconstructive and aesthetic breast surgery in three medical institutions in Russia and China.</p> <p><bold>Materials and methods.</bold> Data from 84 patients in three centers were retrospectively analyzed: the Ruili Medical Cosmetic Hospital (RMCH, China, n=36), the Southeastern Hospital at Xiamen University (SEH, China, n=22), and the University Clinical Hospital No. 4 of the Sechenov University (UCH No. 4, Russia, n=26). Parameters of anesthesia, methods of harvesting and preparing AAT and PRP, the ratio of components, injection technique, and postoperative management were compared. Esthetic outcomes, graft survival, and complications were assessed.</p> <p><bold>Results.</bold> In RMCH and SEH (aesthetic breast surgery), the volume of injected AAT was 150–250 mL per breast. The breast circumference increased by 3.19-6.28 cm after 6–12 months; 86–89% of patients achieved satisfactory results after 1–2 procedures. In UCH No. 4 (reconstruction after breast cancer), the volume of injected AAT was 50–100 mL per breast. The thickness of the subcutaneous fat layer increased by 1.4 cm (at 6 months) and 1.1 cm (at 12 months). Ten patients achieved the result after one procedure, while 16 required 2–3 lipofilling procedures. No complications were reported, and the graft survival rate did not correlate with the AAT volume.</p> <p><bold>Conclusion.</bold> PRP-assisted AATT is effective and safe for aesthetic and reconstructive breast surgery. In patients with malignancies, a smaller volume of AAT and repeated procedures can provide correction of cicatricial defects and improve psychosocial status. Further research is needed to standardize the techniques.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Введение.</bold> Трансплантация аутологичной жировой ткани (ТАЖТ) с обогащенной тромбоцитами плазмой (ОТП) активно применяется в реконструктивной и эстетической хирургии молочной железы (МЖ). Однако различия в методиках подготовки ОТП и ТАЖТ, а также в подходах к ведению пациенток с раком молочной железы (РМЖ) и без онкологического заболевания требуют сравнительного анализа для оптимизации клинических результатов.</p> <p><bold>Цель.</bold> Сравнить хирургические методики и результаты ОТП-ассистированной ТАЖТ в реконструктивной и эстетической хирургии МЖ в трех медицинских учреждениях России и Китая.</p> <p><bold>Материалы и методы.</bold> Проведен ретроспективный анализ данных 84 пациенток из трех центров: медицинской косметологической больницы «Жуйли» (ЖБ, Китай, n=36), Юго-восточной больницы при Сямэньском университете (ЮВБ, Китай, n=22) и Университетской клинической больницы №4 ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет) (УКБ №4, Россия, n=26). Сравнивали параметры анестезии, методы забора и подготовки АЖТ и ОТП, соотношение компонентов, технику инъекции и послеоперационное ведение. Оценили эстетические результаты, приживаемость трансплантата и осложнения.</p> <p><bold>Результаты.</bold> В ЖБ и ЮВБ (эстетическая маммопластика) объем введенной АЖТ составил 150–250 мл/МЖ, обхват груди увеличился на 3,19–6,28 см через 6–12 мес, 86–89% пациенток достигли удовлетворительных результатов после 1–2 процедур. В УКБ №4 (реконструкция после РМЖ) объем АЖТ составил 50–100 мл/МЖ, толщина подкожно-жирового слоя увеличилась на 1,4 см (6 мес) и 1,1 см (12 мес), 10 пациенток достигли результата после одной процедуры, 16 потребовалось 2–3 липофилинга. Осложнений не зафиксировано, приживаемость трансплантата не зависела от объема АЖТ.</p> <p><bold>Заключение.</bold> ОТП-ассистированная ТАЖТ эффективна и безопасна для эстетической и реконструктивной хирургии МЖ. У пациенток с онкологией меньший объем АЖТ и повторные процедуры обеспечивают коррекцию рубцовых дефектов и улучшение психосоциального статуса. Необходимы дальнейшие исследования для стандартизации методик.</p></trans-abstract><kwd-group xml:lang="en"><kwd>breast cancer</kwd><kwd>autologous adipose tissue</kwd><kwd>platelet-rich plasma</kwd><kwd>reconstructive surgery</kwd><kwd>aesthetic breast surgery</kwd><kwd>lipofilling</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>рак молочной железы</kwd><kwd>аутологичная жировая ткань</kwd><kwd>обогащенная тромбоцитами плазма</kwd><kwd>реконструктивная хирургия</kwd><kwd>эстетическая маммопластика</kwd><kwd>липофилинг</kwd></kwd-group><funding-group><funding-statement xml:lang="en">This study is funded by the China Scholarship Council (CSC) No. 202308090559.</funding-statement><funding-statement xml:lang="ru">Эта работа финансируется Китайским стипендиальным советом (CSC) № 202308090559.</funding-statement></funding-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Cecerska-Heryć E, Goszka M, Serwin N, et al. Applications of the regenerative capacity of platelets in modern medicine. Cytokine Growth Factor Rev. 2022;64:84-94. DOI:10.1016/j.cytogfr.2021.11.003</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Mijiritsky E, Assaf HD, Peleg O, et al. Use of PRP, PRF and CGF in Periodontal Regeneration and Facial Rejuvenation – A Narrative Review. Biology (Basel). 2021;10(4):317. DOI:10.3390/biology10040317</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Collins T, Alexander D, Barkatali B. Platelet-rich plasma: a narrative review. EFORT Open Rev. 2021;6(4):225-35. DOI:10.1302/2058-5241.6.200017</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Modarressi A. Platlet Rich Plasma (PRP) Improves Fat Grafting Outcomes. World J Plast Surg. 2013;2(1):6-13.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Jin R, Zhang L, Zhang YG. Does platelet-rich plasma enhance the survival of grafted fat? An update review. Int J Clin Exp Med. 2013;6(4):252-8.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Gentile P, Di Pasquali C, Bocchini I, et al. Breast reconstruction with autologous fat graft mixed with platelet-rich plasma. Surg Innov. 2013;20(4):370-6. DOI:10.1177/1553350612458544</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Almeida NR, Brenelli FP, Dos Santos CC, et al. Comparative study of surgical and oncological outcomes in oncoplastic versus non oncoplastic breast-conserving surgery for breast cancer treatment. JPRAS Open. 2021;29:184-94. DOI:10.1016/j.jpra.2021.05.010</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Roy N, Downes MH, Ibelli T, et al. The psychological impacts of post-mastectomy breast reconstruction: a systematic review. Ann Breast Surg. 2024;8:19. DOI:10.21037/abs-23-33</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Dai L, Li B, Xu S. [Application of Platelet Rich Plasma Combined with Autologous Fat Transplantation for Augmentation Mammoplasty. Chinese Journal of Aesthetic Medicine. 2018;27(2):1008-6455 (in Chinese)].</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Zheng Y, Zeng Y, Liu X, et al. [Effect of breast augmentation with platelet-rich plasma combined with autologous fat transplantation and perioperative nursing intervention. Modern Nurse. 2021;28(36) (in Chinese)]. DOI:10.19793/j.cnki.1006-6411.2021.36.018.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Han C, Chen C, Lu N, et al. Platelet-Rich Plasma Inhibits Breast Cancer Proliferation. Clin Med Insights Oncol. 2024;18:11795549241298978. DOI:10.1177/11795549241298978</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Хоробрых Т.В., Баранова М.П., Ван Ш., и др. Применение обогащенной тромбоцитами плазмы при онкопластической реконструкции молочной железы: обзор современного состояния и перспектив. Естественные и технические науки. 2024;06(2):216-23 [Khorobrykh TV, Baranova MP, Wang Sh, et al. Use of platelet rich plasma in oncoplastic breast reconstruction: A review of the current state and prospects. Modern Science: actual problems. 2024;06(2):216-23 (in Russian)]. DOI:10.37882/2223-2966.2024.6-2.39</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Wu M, Karvar M, Liu Q, et al. Comparison of Conventional and Platelet-Rich Plasma-Assisted Fat Grafting: A Systematic Review and Meta-analysis. J Plast Reconstr Aesthet Surg. 2021;74(11):2821-30. DOI:10.1016/j.bjps.2021.05.046</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Wang S, Liu Z, Wang J, et al. Platelet-rich plasma (PRP) in nerve repair. Regen Ther. 2024;27:244-50. DOI:10.1016/j.reth.2024.03.017</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>D'Esposito V, Passaretti F, Perruolo G, et al. Platelet-Rich Plasma Increases Growth and Motility of Adipose Tissue-Derived Mesenchymal Stem Cells and Controls Adipocyte Secretory Function. J Cell Biochem. 2015;116(10):2408-18. DOI:10.1002/jcb.25235</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Lubaba AAA, Zainab J, Saif SA, et al. The anti-inflammatory effect of the platelet-rich plasma in the periodontal pocket. Eur J Dent. 2018;12(4):528-31. DOI:10.4103/ejd.ejd_49_18</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Menchisheva Y, Mirzakulova U, Yui R. Use of platelet-rich plasma to facilitate wound healing. Int Wound J. 2019;16(2):343-53. DOI:10.1111/iwj.13034</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Phoebe LKW, Lee KWA, Chan LKW, et al. Use of platelet rich plasma for skin rejuvenation. Skin Res Technol. 2024;30(4):e13714. DOI:10.1111/srt.13714</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Pensato R, Al-Amer R, La Padula S. What About the Rheological Properties of PRP/Microfat Mixtures in Fat Grafting Procedure? Aesthetic Plast Surg. 2024;48(15): 3000-1. DOI:10.1007/s00266-023-03478-w</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Schipper JAM, Vriend L, Tuin AJ, et al. Supplementation of Facial Fat Grafting to Increase Volume Retention: A Systematic Review. Aesthet Surg J. 2022;42(12):Np711-np27. DOI:10.1093/asj/sjac122</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Pittermann A, Radtke C. Psychological Aspects of Breast Reconstruction after Breast Cancer. Breast Care (Basel). 2019;14(5):298-301. DOI:10.1159/000503024</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Eichler C, Baucks C, Üner J, et al. Platelet-Rich Plasma (PRP) in Breast Cancer Patients: An Application Analysis of 163 Sentinel Lymph Node Biopsies. Biomed Res Int. 2020;2020:3432987. DOI:10.1155/2020/3432987</mixed-citation></ref></ref-list></back></article>
